Quantum Health Signs AI Drug Discovery Agreement with PYC Therapeutics, Google Cloud and GoPomelo

Quantum Health enters into a four way agreement with PYC Therapeutics Ltd (ASX:PYC), Google Cloud and GoPomelo. The Project has been set up to build an AI to identify new drug targets. The Project will be making use of PYC’s peptide data set and Google’s protein modelling AI, Alphafold and its successors. Quantum Health will be providing the Special Purpose Vehicle to deliver the Project.